Ondine’s innovative light-activated antimicrobial treatment has the potential to become the first FDA-approved nasal decolonization treatment for the prevention of surgical site infections. The ...
Earlier, the Vatican had said the 88-year-old had a “polymicrobial infection of the respiratory tract” and pneumonia in both lungs, with tests indicating a “complex clinical picture.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results